跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 217 条关于
“VWF”
全部
217
临床试验
117
药物
80
机构
0
资讯
20
2个月前
Hemab Therapeutics Unveils HMB-002 Proof-of-Mechanism Data in VWD and Announces Novel Antifibrinolytic HMB-003 at ISTH 2026
去年
FDA Expands Vonvendi Approval to Include Pediatric von Willebrand Disease Patients
去年
KU Leuven Spin-off Hemastatx Develops First Therapy Targeting Root Cause of Severe Bleeding Disorder
去年
TargED Biopharmaceuticals Initiates Phase 1 Trial of TGD001 for Thrombotic Disorders
10个月前
Hemab Therapeutics Secures $157 Million Series C to Advance First-in-Class Treatments for Rare Bleeding Disorders
去年
Sobi Showcases Efanesoctocog Alfa Data from XTEND Phase 3 Program at WFH 2025 Summit
9个月前
Star Therapeutics Reports Promising Phase 1/2 Data for VGA039 in Von Willebrand Disease, Showing 73-100% Reduction in Bleeding Episodes
9个月前
Sanofi Secures Chinese Approval for Two Rare Blood Disorder Therapies Qfitlia and Cablivi
2年前
Basking Biosciences Initiates Phase II Trial of BB-031 for Acute Ischemic Stroke
3年前
Vega Therapeutics' VGA039 Receives FDA Orphan Drug Designation for Von Willebrand Disease
第 1 页,共 2 页
上一页
下一页